Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Anne Marie Lindegaard, Katrin Håkansson, Mogens Bernsdorf, Anita B. Gothelf, Claus A. Kristensen, Lena Specht, Ivan R. Vogelius & Jeppe Friborg. (2023) A systematic review on clinical adaptive radiotherapy for head and neck cancer. Acta Oncologica 62:11, pages 1360-1368.
Read now
Read now
Simon Long Krogh, Carsten Brink, Ebbe Laugaard Lorenzen, Eva Samsøe, Ivan Richter Vogelius, Ruta Zukauskaite, Birgitte Vrou Offersen, Jesper Grau Eriksen, Olfred Hansen, Jørgen Johansen, Agon Olloni, Christina H. Ruhlmann, Lone Hoffmann, Henrik Dahl Nissen, Martin Skovmos Nielsen, Karen Andersen, Cai Grau & Christian Rønn Hansen. (2023) A national repository of complete radiotherapy plans: design, Results, and experiences. Acta Oncologica 62:10, pages 1161-1168.
Read now
Read now
Katrin Håkansson, Anne Marie Lindegaard, Mogens Bernsdorf, Anita Gothelf, Claus Andrup Kristensen, Lena Specht, Jeppe Friborg & Ivan Vogelius. (2023) A comparison of loco-regional relapse pattern in HPV positive vs negative oropharyngeal cancers following radiotherapy; relation to pretreatment FDG-PET and radiotherapy target volumes. Acta Oncologica 62:9, pages 1028-1035.
Read now
Read now
Maja B. Sharma, Kenneth Jensen, Jeppe Friborg, Bob Smulders, Elo Andersen, Eva Samsøe, Jørgen Johansen, Christian R. Hansen, Maria Andersen, Martin S. Nielsen, Mads V. Filtenborg, Jintao Ren, Stine S. Korreman, Jens Overgaard & Cai Grau. (2022) Target coverage and local recurrences after radiotherapy for sinonasal cancer in Denmark 2008–2015. A DAHANCA study. Acta Oncologica 61:2, pages 120-126.
Read now
Read now
Jens Overgaard, Ludvig Paul Muren, Morten Høyer & Cai Grau. (2019) BIGART 2019 – adapting to the future. Acta Oncologica 58:10, pages 1323-1327.
Read now
Read now
C. R. Hansen, J. Friborg, K. Jensen, E. Samsøe, L. Johnsen, R. Zukauskaite, C. Grau, C. Maare, J. Johansen, H. Primdahl, Å. Bratland, C. A. Kristensen, M Andersen, J. G. Eriksen & J. Overgaard. (2019) NTCP model validation method for DAHANCA patient selection of protons versus photons in head and neck cancer radiotherapy. Acta Oncologica 58:10, pages 1410-1415.
Read now
Read now
Jacob Kinggaard Lilja-Fischer, Mette Saksø, Magnus Stougaard, Torben Steiniche & Jens Overgaard. (2019) Distinguishing recurrence and new primary tumor as well as the origin of neck metastases in head and neck cancer clinical trials by targeted DNA sequencing. Acta Oncologica 58:10, pages 1506-1508.
Read now
Read now
Jan Folkvard Evensen, Hanne Sand Hansen, Marie Overgaard, Jørgen Johansen, Lisbeth Juhler Andersen & Jens Overgaard. (2019) DAHANCA 9 – a randomized multicenter study to compare accelerated normo-fractionated radiotherapy with accelerated hyperfractionated radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC). Acta Oncologica 58:10, pages 1502-1505.
Read now
Read now
Carsten Brink, Ebbe L. Lorenzen, Simon Long Krogh, Jonas Westberg, Martin Berg, Ingelise Jensen, Mette Skovhus Thomsen, Esben Svitzer Yates & Birgitte Vrou Offersen. (2018) DBCG hypo trial validation of radiotherapy parameters from a national data bank versus manual reporting. Acta Oncologica 57:1, pages 107-112.
Read now
Read now
Cai Grau, Morten Høyer, Per Rugaard Poulsen, Ludvig Paul Muren, Stine Sofia Korreman, Kari Tanderup, Jacob Christian Lindegaard, Jan Alsner & Jens Overgaard. (2017) Rethink radiotherapy – BIGART 2017. Acta Oncologica 56:11, pages 1341-1352.
Read now
Read now
Articles from other publishers (16)
Ruta Zukauskaite, Morten Horsholt Kristensen, Jesper Grau Eriksen, Jørgen Johansen, Eva Samsøe, Lars Johnsen, Camilla Kjær Lønkvist, Cai Grau & Christian Rønn Hansen. (2024) Comparison of 3-year local control using DAHANCA radiotherapy guidelines before and after implementation of five millimetres geometrical GTV to high-dose CTV margin. Radiotherapy and Oncology 196, pages 110284.
Crossref
Crossref
Morten Horsholt Kristensen, Anne Ivalu Sander Holm, Christian Rønn Hansen, Ruta Zukauskaite, Eva Samsøe, Christian Maare, Jørgen Johansen, Hanne Primdahl, Åse Bratland, Claus Andrup Kristensen, Maria Andersen, Jens Overgaard & Jesper Grau Eriksen. (2024) High-dose loco-regional pattern of failure after primary radiotherapy in p16 positive and negative head and neck squamous cell carcinoma – A DAHANCA 19 study. Clinical and Translational Radiation Oncology 46, pages 100772.
Crossref
Crossref
Paul-Henry Mackeprang, Katarina Bryjova, Astrid E. Heusel, Dominik Henzen, Melissa Scricciolo & Olgun Elicin. (2024) Consideration of image guidance in patterns of failure analyses of intensity-modulated radiotherapy for head and neck cancer: a systematic review. Radiation Oncology 19:1.
Crossref
Crossref
Trada Yuvnik, Low Chia, O' Connor Laura, Tieu Thi Tieu, Kumar Mahesh, Beeksma Bradley, Cope Daron & Wratten Chris. (2023) Differences in geometric patterns of failure in human papillomavirus (HPV)‐associated and HPV‐non‐associated oropharyngeal cancer after definitive radiotherapy. Head & Neck 46:3, pages 552-560.
Crossref
Crossref
Heleen Bollen, Akos Gulyban & Sandra Nuyts. (2023) Impact of consensus guidelines on delineation of primary tumor clinical target volume (CTVp) for head and neck cancer: Results of a national review project. Radiotherapy and Oncology 189, pages 109915.
Crossref
Crossref
Kerstin Clasen, Marcel Nachbar, Sergios Gatidis, Daniel Zips, Daniela Thorwarth & Stefan Welz. (2023) Impact of MRI on target volume definition in head and neck cancer patients. Radiation Oncology 18:1.
Crossref
Crossref
MJ García-Anaya, S. Segado-Guillot, J. Cabrera-Rodríguez, MD Toledo-Serrano, JA Medina-Carmona & J. Gómez-Millán. (2023) Dose and volume de-escalation of radiotherapy in head and neck cancer. Critical Reviews in Oncology/Hematology 186, pages 103994.
Crossref
Crossref
Laura Patricia Kaplan, Anne Ivalu Sander Holm, Jesper Grau Eriksen, Ben J.M. Heijmen, Stine Sofia Korreman & Linda Rossi. (2023) Patient anatomy-specific trade-offs between sub-clinical disease coverage and normal tissue dose reduction in head-and-neck cancer. Radiotherapy and Oncology 182, pages 109526.
Crossref
Crossref
Karen Lycke Wind, Karen-Lise Garm Spindler, Christina Maria Lutz, Lars Nyvang & Camilla Kronborg. (2023) Estimated dose to site of loco-regional recurrence after radiotherapy in anal cancer using point of origin methods. Physics and Imaging in Radiation Oncology 25, pages 100424.
Crossref
Crossref
Pernille Lassen, Shao Hui Huang, Jie Su, John Waldron, Maria Andersen, Hanne Primdahl, Jørgen Johansen, Claus Andrup Kristensen, Elo Andersen, Jesper Grau Eriksen, Christian Rønn Hansen, Jan Alsner, Jacob Lilja‐Fisher, Scott V. Bratman, Jolie Ringash, John Kim, Andrew Hope, Anna Spreafico, John Almeida, Wei Xu, Brian O'Sullivan & Jens Overgaard. (2021)
Treatment outcomes and survival following definitive (chemo)radiotherapy in
HPV
‐positive oropharynx cancer: Large‐scale comparison of
DAHANCA
vs
PMH
cohorts
. International Journal of Cancer 150:8, pages 1329-1340.
Crossref
Crossref
Heleen Bollen, Julie van der Veen, Annouschka Laenen & Sandra Nuyts. (2021) Recurrence Patterns After IMRT/VMAT in Head and Neck Cancer. Frontiers in Oncology 11.
Crossref
Crossref
Kenneth Jensen, Gina Al-Farra, Danijela Dejanovic, Jesper G. Eriksen, Annika Loft, Christian R. Hansen, Frank A. Pameijer, Ruta Zukauskaite & Cai Grau. (2021) Imaging for Target Delineation in Head and Neck Cancer Radiotherapy. Seminars in Nuclear Medicine 51:1, pages 59-67.
Crossref
Crossref
Mette Saksø, Lise Saksø Mortensen, Hanne Primdahl, Jørgen Johansen, Jesper Kallehauge, Christian Rønn Hansen & Jens Overgaard. (2020) Influence of FAZA PET hypoxia and HPV-status for the outcome of head and neck squamous cell carcinoma (HNSCC) treated with radiotherapy: Long-term results from the DAHANCA 24 trial (NCT01017224). Radiotherapy and Oncology 151, pages 126-133.
Crossref
Crossref
Mette Saksø, Kenneth Jensen, Maria Andersen, Christian Rønn Hansen, Jesper Grau Eriksen & Jens Overgaard. (2020) DAHANCA 28: A phase I/II feasibility study of hyperfractionated, accelerated radiotherapy with concomitant cisplatin and nimorazole (HART-CN) for patients with locally advanced, HPV/p16-negative squamous cell carcinoma of the oropharynx, hypopharynx, larynx and oral cavity. Radiotherapy and Oncology 148, pages 65-72.
Crossref
Crossref
Sandra Nuyts & Sarah Deschuymer. 2021. Head and Neck Cancer Imaging. Head and Neck Cancer Imaging
495
517
.
C.N. Andreassen, J.G. Eriksen, K. Jensen, C.R. Hansen, B.S. Sørensen, P. Lassen, J. Alsner, L.M.H. Schack, J. Overgaard & C. Grau. (2018) IMRT – Biomarkers for dose escalation, dose de-escalation and personalized medicine in radiotherapy for head and neck cancer. Oral Oncology 86, pages 91-99.
Crossref
Crossref